FDA Issues Emergency Use Authorization for Impella RP in COVID-19 FDA Issues Emergency Use Authorization for Impella RP in COVID-19
The authorization allows use of the temporary heart pump in the treatment of right heart failure or decompensation, including pulmonary embolism, caused by COVID-19 complications.FDA Approvals
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news
More News: Cardiology | COVID-19 | Emergency Medicine | Heart | Heart Failure | Pulmonary Thromboembolism